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Abstract This review covers the histopathology and
pathogenesis of non-infectious inflammatory diseases of
the sinonasal tract, in particular, sarcoidosis, granuloma-
tous vasculitides Wegener, Churg–Strauss), relapsing
polychondritis, eosinophilic angiocentric fibrosis, chronic
rhinosinusitis and nasal perforations. Molecular associa-
tions and mechanisms are emphasised to assist pathologists
to put their observations into the context of clinical, genetic
and environmental influences on patients’ diseases.
Keywords Nose and paranasal sinuses  Rhinosinusitis 
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Introduction
Non-infectious inflammatory diseases of the sinonasal tract
include a spectrum of common and uncommon conditions,
the aetiology and pathogenesis involving genetic, immuno-
logical and environmental influences. The histopathological
features are well described but often elusive in biopsy
material. This review focusses on recent advances in the
understanding of the molecular and cellular pathophysiology
of these diseases to help pathologists put their observations
into the clinical context.
Sarcoidosis
Sinonasal involvement in sarcoidosis is usually part of
multisystem disease, but patients may present with chronic
rhinosinusitis, nasal obstruction and nasal crusting. The
clinico-pathologic features required for diagnosis [1] are:
• Mucoperiosteal thickening or opacification of a sinus in
imaging.
• Histopathologic demonstration of non-caseating gran-
ulomata in the upper respiratory tract. Stains for fungi
and mycobacteria should be negative, and there should
be no vasculitis or cholesterol crystals.
• Negative serology for syphilis and anti-neutrophil
cytoplasmic antibody.
• Exclusion of other disease processes associated with
granulomatous inflammation, including tuberculosis,
Wegener’s granulomatosis, and fungal infection.
Four clinical patterns of disease are identified: mucosal
hypertrophy, mucosal atrophy, nasal destruction and nasal
enlargement [2]. Histological and other laboratory inves-
tigations may be required to resolve some of the clinical
differential diagnoses, although biopsies are often non-
specific (Table 1).
Immunology and Genetic Susceptibility
Sarcoidosis involves a dysregulated immune response to a
range of environmental stimuli in genetically susceptible
people. Possible environmental factors include fungi,
inorganic particles and insecticides [3]. Sarcoidosis is 2.5
times more common in the siblings and parents of affected
patients and is three times more common and more severe
in African Americans than European Americans [3]. Gen-
ome wide surveys have demonstrated linkage with the
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NOTCH4 gene in African Americans and show consistent
linkage with polymorphisms of the HLA-DRA, HLA-DRB
(HLA-B8/DR3 haplotype and HLADRB*1101) and HLA-
DRC genes [3–5]. There is a significant overlap of the
molecular pathology of sarcoidosis and that of other
immunologically mediated inflammatory disorders, with a
prominent role of the drug-targetable IL23/TH17-signaling
pathway [5].
Histopathology
The diagnostic histological features of mucosal biopsies
comprise non-caseating epithelioid cell granulomas asso-
ciated with an infiltrate of small T lymphocytes (Fig. 1a).
Multinucleate cells are infrequent and there is rarely more
than minimal necrosis. With time, increasing fibrosis is
associated with the granulomatous response.
Granulomatosis with Polyangiitis (GPA,
Wegener’s Granulomatosis)
Terminology
Small vessel vasculitides are grouped into immune com-
plex vasculitis and those vasculitis syndromes associated
with anti-neutrophil cytoplasmic antibodies (ANCA) in
which there is little evidence of immune complex deposi-
tion [6]. ANCA-associated necrotising vasculitides (AAV)
include microscopic polyangiitis, granulomatosis with
polyangiitis (GPA, Wegener) and eosinophilic granulo-
matosis with polyangiitis (EGPA, Churg–Strauss).
Aetiology and Pathogenesis
The aetiology of GPA is unknown but is likely to involve a
range of environmental factors, including micro-organisms,
in genetically susceptible individuals. GPA is associated in
80 % patients with c-ANCA antibodies to proteinase 3, and
in 20 % patients with antibodies to myeloperoxidase.
Proteinase 3 is found in the azurophilic granules of neu-
trophils and is expressed on the membranes of secretory
vacuoles and on the surface of resting neutrophils; the
extent of this constitutive expression is very variable
(0–100 % neutrophils) and is genetically determined [7].
The characteristic cytokine profile in GPA indicates a TH1/
TH17 response with the production of cytokines such as
TNF-a and IFN-c which are probably linked to the gran-
ulomatous response. HLA-1 involvement is also likely, but
the strongest HLA associations are with HLA-DR4 and
HLA-DPB1 [4].
Clinical Features
GPA affects males and females equally, with most patients
presenting over the age of 45 years with sinonasal symp-
toms of obstruction, bleeding or crusting associated with
pulmonary infiltrates and renal impairment [4, 8]. Even in
the absence of active disease, the loss of the normal
mucosal functions may lead to dry mucosa and repeated
infections. Chronic disease may cause meatal obstruction,
sinus neo-ossification, septal destruction and the collapse
of the nasal cartilages. Oral ulceration, gingivitis and
subglottic stenosis are seen in a minority of patients.
Table 1 Clinical subtypes of sarcoidosis with their corresponding differential diagnoses
Clinical subtype of sinonasal sarcoidosis Differential diagnosis Diagnostic clinical and histological featuresa
Atrophic Wegener’s granulomatosis Granulomatous vasculitis
Cicatricial pemphigus Skin and other mucosal involvement
Linear IgA dermatosis Positive IgA immunofluorescence
Rhinoscleroma Characteristic histology
Atrophic rhinitis Extreme crusting and nasal fetor
Hypertrophic Allergic rhinitis
Fungal or bacterial rhinosinusitis Specific organisms
Churg–Strauss Eosinophilic vasculitis
Destructive Wegener’s granulomatosis Granulomatous vasculitis
NK/T cell lymphoma Atypical lymphoid infiltrate
Cocaine abuse Clinical history, p-ANCA
Nasal enlargement Massive polyposis
Fibrous dysplasia Imaging studies
a These diagnostic clinical and histological features may not be present in all patients
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Treatment with corticosteroids and immunosuppressive
agents has greatly reduced the mortality of GPA, with
10-year survival rates now exceeding 80 % [8]. Treatment
associated morbidity is a challenge and biological response
modifiers targeting proteinase 3 and cathepsin C may
become more important.
Histopathology
Most mucosal biopsies show non-specific active chronic
inflammation. The characteristic features, when present,
are irregular areas of necrosis associated with multinucle-
ate cells and poorly formed epithelioid cell granulomas
associated with T lymphocytes and vasculitis Fig. 1b).
Vasculitis affects small and medium-sized vessels and
ranges from leucocytoclastic vasculitis to classical vas-
culitis with fibrinoid necrosis [9] (Fig. 1c, d). Biopsies
should be used to exclude possible differential diagnoses
including infectious granulomas, sarcoidosis, and mucosal
malignancies, particularly NK/T cell lymphoma.
Eosinophilic Granulomatosis with Polyangiitis
(EGPA, Churg–Strauss Syndrome)
EGPA is a rare systemic vasculitis that was first described
in patients diagnosed as polyarteritis nodosa with necro-
tising vasculitis, but who showed tissue and blood eosi-
nophilia and extravascular granulomas [10]. Patients have
symptoms of allergic rhinitis, polyposis and sinusitis and a
history of asthma [11]. Clinically significant disease often
affects the lungs, skin and kidneys, although severe renal
disease is uncommon. Consensus recommendations for
evaluation and management have been published [12].
Diagnosing EGPA implies biopsy-proven vasculitis or a
strong clinical surrogate, but either can be difficult to
Fig. 1 a Nasal sarcoidosis. Irregular, pale epithelioid cell granulomas
are surrounded by small lymphocytes. b Granulomatosis with
polyangiitis (Wegener). Poorly formed epithelioid and multinucleate
cell granulomas are associated with small lymphocytes.
c Granulomatosis with polyangiitis (Wegener). Disruption of the
wall of this small mucosal vessel is seen on H&E staining and d on
staining for elastic tissue (EVG)
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obtain. Within the clinical contexts of asthma with
eosinophilia, asthma with systemic manifestations or with
extrapulmonary disease, a biopsy demonstrating small- or
medium-sized-vessel vasculitis or pauci-immune crescentic
glomerulonephritis, strongly supports a diagnosis of
EGPA. Mucosal biopsies typically show an eosinophil-rich
inflammatory infiltrate and may also show vasculitis and
granulomatous inflammation (Fig. 2a) [11].





present in this nasal biopsy.
b Relapsing polychondritis.
Cartilage erosion by
mononuclear cells and vascular
granulation tissue
Fig. 3 Eosinophilic
angiocentric fibrosis. Late stage
disease with a dense
perivascular fibrosis and b a
scanty infiltrate of plasma cells
and eosinophils
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Immunopathology
A perinuclear immunofluorescent pattern detecting ANCA
to myeloperoxidase (MPO) is the most common EGPA
ANCA-positivity finding. Anti-proteinase-3 (PR3) ANCA
antibodies have been reported in EGPA, but are unusual.
ANCA-positive patients are more likely to have a vas-
culitic phenotype with glomerulonephritis and mononeu-
ritis multiplex, while the prognosis of ANCA-negative
patients is poorer, possibly because of their higher fre-
quency of cardiomyopathy [12]. The inflammatory
response in EGPA is predominant related to TH2 lym-
phocytes. Associated HLA alleles are HLA-DRB1, HLA-
DRB3 and HLA-DRB3 genes but not with HLA-DPB140
(as in GPA) [4].
Relapsing Polychondritis
Relapsing polychondritis is a rare disease of young and
middle aged adults with recurrent painful episodes of acute
inflammation that destroy the nasal and aural cartilages.
Tracheal chondritis leads to airway obstruction and pneu-
monia. Other manifestations include migratory arthritis,
ocular inflammation, cardiac and neurological disease [13].
About one-third of patients have other autoimmune diseases
and there is overlap with Behcet’s disease—the so-called
MAGIC syndrome ofmouth and genital ulcers with inflamed
cartilage [14]. Relapsing polychondritis is a TH1 mediated
disease and, although the target antigens are not known,
human and experimental studies suggest that collagen type II
and the cartilage matrix protein matrilin-1 are likely candi-
dates [13]. Biopsies of involved cartilage shows loss of
mucopolysaccharide matrix, disruption of elastic fibres and
microcysts, with erosion by CD4? T lymphocytes (Fig. 2b).
Neutrophils may be present in the early stages and there is
usually perichondrial granulation tissue and fibrosis [13, 15].
Eosinophilic Angiocentric Fibrosis
Eosinophilic angiocentric fibrosis is an uncommon, idio-
pathic inflammatory condition of the nose affecting mid-
dle-aged adults with progressive fibrosis leading to nasal
Fig. 4 a Chronic rhinosinusitis. Mucosal gland hyperplasia. b Chronic rhinosinusitis. Inflammatory infiltrate rich in eosinophils. c Inflammatory
nasal polyp with haemorrhage and abundant fibrin. d Inflammatory nasal polyp with partly calcified cholesterol granuloma
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obstruction. EAF is considered to be one of the IgG4
related diseases which are typified by storiform fibrosis,
obliterative phlebitis, many IgG4-positive plasma cells, a
ratio of IgG4:total IgG plasma cells of[40 % and raised
serum IgG4 [16, 17]. In the early stages, there is an eosi-
nophil-rich inflammatory exudate around vessels. In later
stages the inflammatory infiltrate is more patchy and mixed
(eosinophils, neutrophils, lymphocytes and plasma cells)
and progresses to onion-skin perivascular fibrosis (Fig. 3).
The clinical and imaging features are non-specific and the
diagnosis is made histologically [18].
Chronic Rhinosinusitis
Chronic rhinosinusitis (CRS) is a common disease, defined
clinically as inflammation of the sinonasal mucosa leading
to symptoms of nasal obstruction and discharge for more
than 3 months. Many factors are implicated in chronic
rhinosinusitis, including genetic, immunological and envi-
ronmental factors [19]. Although antimicrobial treatment
has little effect on the symptoms of CRS, bacteria and
fungi are implicated in the pathogenesis of CRS through
their involvement in the biofilms that form on the surface
of the sinonasal mucosa. Biofilms are collections of micro-
organisms that grow in a self-produced matrix, conditions
that lead to modifications in gene expression. Sinonasal
biofilms contain Staphylococcus aureus, Streptococcus
pneumonia and Pseudomonas aeruginosa, sometimes
associated with fungi such as Aspergillus sp. [4].
The inherited disorders associated with CRS are cystic
fibrosis and primary ciliary dyskinesia. Cystic fibrosis is
caused by a mutation in the cystic fibrosis transmembrane
conductance regulator gene (7q31.2) leading to a defect in
chloride transport and thick mucin. As the life expectancy
of patients with cystic fibrosis has increased in recent years,
most patients develop CRS and nasal polyposis. Histolog-
ically, polyps in patients with CF are similar to those in
other forms of CRS and there is a similar pattern of gene
expression in mucosal glands, with the exception of
increased expression in CF patients of the orthodenticle
homeobox 2 gene, OTX2 [4, 20].
Primary ciliary dyskinesia syndrome is a group of con-
ditions in which structural and functional abnormalities of
cilia lead to CRS with polyps and recurrent infections.
About 50 % of patients have Kartagener syndrome with
CRS, situs inversus and bronchiectasis [21].
Inhaled water-soluble irritants such as formaldehyde,
ammonia and sulphur dioxide readily dissolve in the sur-
face mucus and may cause changes in the structure and
function of the mucosa leading to olfactory dysfunction,
sensory irritation and rhinosinusitis. Occupational rhinitis
is associated with a wide range of chemicals and may be
non-allergic or allergic in pathogenesis [22].
Immunopathology
For clinical purposes, it is usual to consider allergic
rhinitis, non-allergic rhinitis and chronic rhinosinusitis as
separate but overlapping conditions, with or without
polyposis (Table 2). Allergic rhinitis is an IgE-mediated
response to inhaled allergens, in which activation of the
TH2 pathway stimulates IL3, IL4, IL5 and IL13 production
leading to local and systemic IgE synthesis. In tropical
urban environments, exposure to dust mites is prevalent
while in other parts of the world multiple allergens are
implicated [23, 24].
Non-infectious non-allergic rhinitis may be influenced
by allergic conditions, medications and hormonal factors,
with a subgroup of patients showing general nasal hyper-
reactivity to inhaled irritants.
Non-allergic rhinitis with eosinophilia syndrome
(NARES) is most prevalent in middle-aged adults who
have symptoms of rhinitis with polyposis in the absence of
atopy. The nasal mucosa and fluid contains eosinophils
[25]. IgE levels are not elevated and anosmia is a promi-
nent feature. The pathophysiology is poorly understood.
Non-allergic rhinitis with a predominance of neutrophils
and/or mast cells has been suggested by some authors to
have different clinical features and treatment [26].
Non allergic non-eosinophilic rhinitis is most prevalent
in middle aged and elderly adults and is related to
mechanical obstruction to drainage and secondary bacterial
infection. Symptoms are triggered by changes in temper-
ature, light intensity and emotion, probably due to hyper-
reactivity of the autonomic nervous system leading to the
release of vasoactive neurotransmitters.
Pathogenesis
The pathogenesis of the inflammatory changes in CRS is
complex [27, 28]. Activated mast cells and fibroblasts
produce proinflammatory cytokines (Il-1, Il-6, interferon-c
and TNF-a) which attract and activate neutrophils and
eosinophils [29]. Lymphocyte subpopulations differ
Table 2 Clinico-pathological subtypes of rhinitis
Allergic rhinitis
Seasonal rhinitis—tree pollen (spring), grass pollen (summer),
weed pollen (late summer) and fungal spores (autumn and
winter)
Perennial rhinitis—allergens found in the faeces of the house
dust mite.
Non-allergic rhinitis with eosinophilia (NARES)
Non-allergic, non-eosinophilic rhinitis
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between patients without polyposis (TH1 predominant with
high levels of interferon-c) and those with polyposis (TH2
predominant with high IL-5 and IgE levels) [27]. Mucosal
tissue remodelling is manifest as breakdown of the extra-
cellular matrix by proteases (MMP-9) leading to pseudo-
cysts, basement membrane thickening by fibronectin and
types I, III and V collagens, and mucosal gland hyperplasia
[29]. TGF-b produced by eosinophils stimulates fibrob-
lasts, as well as upregulating VEGF expression which
induces angiogenesis and oedema [28]. Tissue eosinophilia
is found in up to 90 % of mucosal biopsies but the role of
eosinophils is uncertain, being found in both allergy and
NARES.
Histopathology
Nasal cytology is of limited value in the assessment of
CRS, but may demonstrate eosinophils. Nasal biopsies are
useful for the exclusion of granulomatous disorders, vas-
culitis and, for unilateral disease, neoplasia. Histologically,
chronic rhinosinusitis is characterised by mucosal thick-
ening with goblet cell hyperplasia (Fig. 4a), submucosal
fibrosis and a non-specific infiltrate of lymphocytes and
plasma cells, with or without eosinophils.
Inflammatory polyps are smooth-surfaced, pink or pale
brown masses up to 3-4 cm in diameter, attached to the
mucosa of the lateral nasal cavity close to the sinus ostia.
Polyps are covered by ciliated respiratory epithelium and
may show immature squamous metaplasia and ulceration.
The epithelial basement membrane is thickened and the
stroma shows marked oedema and myxoid change with
pseudocystic degeneration and variable numbers of blood
vessels and myofibroblasts. The intensity and type of
inflammatory infiltrate varies markedly both within and
between polyps; eosinophils, lymphocytes and plasma cells
are present and eosinophils often predominate (Fig. 4b).
Polyps from patients with asthma show more basement
membrane thickening, goblet cell hyperplasia and eosino-
philic infiltration than polyps from patients without asthma
[30], but this is not of practical importance.
Secondary changes that may create problems in diagnosis
include ulceration and infection with a predominantly neu-
trophilic infiltrate, fibrosis, infarction, granulation tissue, the
deposition of dense fibrinous material resembling amyloid
(Fig. 4c), cartilaginous and osseous metaplasia, and
cholesterol granuloma formation with calcification (Fig. 4d).
Nasal Septal Perforation
Nasal septal perforation may be caused by local trauma
(‘nose-pickers’ perforation), inhalation of toxic substances
such as cocaine or intranasal steroid and decongestant
sprays, infective and non-infective granulomatous diseases
and nasal malignancies [31]. Occupational exposure to
corrosive chemicals such as strong acids and alkalis,
chromates used in the electroplating industry, nickel,
arsenic and copper may lead to perforation [32]. Biopsies
are taken from the mucosal edge of a perforation to exclude
specific pathologies, and usually show non-specific acute
inflammatory debris, inflamed granulation tissue and
reactive changes in the adjacent epithelium.
Cocaine-Induced Midline Destructive Lesions
(CIMDL)
CIMDL most probably arise from the intense vasocon-
striction and extensive destruction of the cartilaginous tis-
sues of the nose following inhalation of cocaine. The main
clinical differential diagnosis is with GPA, and there is
substantial overlap in histopathology and autoantibody
profiles. Biopsies tend to show non-specific chronic
inflammation and necrosis but may include leucocytoclas-
tic vasculitis and a granulomatous reaction to foreign
material which should be distinguished from the more
deeply situated granulomas with necrosis sometimes seen
in GPA [33]. CIMDL is associated with c-ANCA and
p-ANCA directed against neutrophil elastase [33].
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